Abstract : The technique of fetal endoscopic tracheal occlusion FETO was developed to totally occlude the fetal trachea using an intratracheal balloon in the treatment of congenital diaphragmatic hernia with lung hypoplasia. To improve this approach, we developed a method for non-contact, rapid destruction of the balloon using high intensity focused ultrasound HIFU , a speci c balloon injection uid, and euthanized rabbits 1 kg . In an initial experiment 5 rabbits , we in ated an intratracheal balloon by injecting in 1.0 ml of uid and demonstrated that HIFU could successfully burst the balloon in all cases, although the tracheal membranous portion and the skin overlying the trachea were injured in 4 and 2 cases, respectively. In our second experiment 6 animals , we in ated the balloon using only 0.5-0.6 ml of fluid. In all cases, HIFU either burst 1 animal or deflated 5 animals the balloon and there was substantially decreased injury of the tracheal membranous portion 2 cases or overlying skin 2 cases . The total HIFU energy output revealed no signi cant difference between the rst and second experimental groups. In conclusion, the intratracheal balloon placed by FETO can be removed using HIFU alone.
Introduction
Congenital diaphragmatic hernia CDH is occasionally associated with severe lung hypoplasia, which can potentially cause prenatal or postnatal death 1 2 . Fetal endoscopic tracheal occlusion FETO is a minimally invasive prenatal procedure used to promote fetal lung growth by occluding the fetal trachea using a balloon fetoscopically in ated inside the trachea 3 4 . Although FETO has been widely adopted with increased success, safe removal of the tracheal occlusion before delivery remains a crucial issue 4 5 . Several procedures have been reported for removing the intratracheal balloon following a FETO procedure including removal of the balloon in a second fetoscopic procedure. However, any prenatal procedure invariably requires a high degree of technical competence and expertise, and this might be problematic in emergency cases involving an unexpected preterm delivery. To overcome this problem, we have developed a relatively safe and simple solution that combines two procedural concepts : a speci cally designed irradiation sequence of high intensity focused ultrasound HIFU and a specifically formulated fluid for balloon in ation. Using animal models, we were able to instantaneously destroy or progressively de ate an intratracheal balloon and open the occluded trachea. In this paper, we report on our research and experimental results and discuss the likelihood of prospectively avoiding a second fetoscopy following the conventional FETO procedure.
Materials and methods
Rabbits Japanese white, male, 1 kg were used in this study to model a human fetus oating in the uterine cavity lled with amniotic uid. Five rabbits were used in experiment 1 and six rabbits in experiment 2. The animals were euthanized then submerged in a water tank lled with degassed water. A fetoscope Karl Storz, Tuttlingen, Germany ; Model 11540AA, Miniature Straight Forward Telescope 0 , 1.3 mm was inserted into the trachea of each rabbit, while injecting water so as not to damage the vocal cords. A balloon BALT Extrusion, Montmorency, France ; GOLDBAL2, 7.0 22 mm when fully expanded, designated injection volume 0.6 ml was placed in the middle of the trachea and in ated by injecting a speci c uid under ultrasound guidance. The injection uid was a per uorocarbon mix of Phase-Change Nanodroplet HITA-CHI, Tokyo, Japan ; 6 7 and Sonazoid Daiichi-Sankyo Pharmaceuticals, Tokyo Japan ; 8 9 .
Both uid components were biologically safe 10 and served to aid the sonographic identi cation and then HIFU destruction of the intratracheal balloon.
Experiment 1
The HIFU irradiation was focused onto the back wall of the balloon, which was inflated with 1.0 ml of the injection uid Fig. 1 . Prior to this experiment, we tested the balloon valve function at 37 by injecting 1.0 ml uid and found no valve leakage over at least 7 days. The HIFU transducer was driven at 1.0 MHz with an aperture diameter of 120 mm and a focal depth of 120 mm. The acoustic intensity of HIFU was 3 kW/cm 2 and the maximum exposure time was 30 s. The HIFU exposure sequence comprised an initial series of high intensity trigger pulses 20 µs seamlessly followed by moderate intensity heating waves 400 ms . If the balloon was not destroyed after the rst cycle of HIFU exposure, the irradiation was repeated under the same conditions for up to three cycles. HIFU irradiation was discontinued when the balloon was destroyed by de ation or bursting.
Experiment 2
As in experiment 1, the balloon was placed inside the trachea and was in ated with 0.5-0.6 ml of the injection uid. HIFU was applied as described in experiment 1 i.e., trigger pulses coupled with heating waves except that the HIFU exposure time was set for 15 s with an interruption of 200 ms between HIFU exposure cycles. This cycle was repeated up to ve times as needed.
To objectively assess the HIFU-induced effects on the in ated intratracheal balloon and on the surrounding animal tissue in both experiments, the total dose of HIFU energy output kJ was determined by multiplying I SATA W/cm 2 , HIFU irradiated area cm 2 , and HIFU exposure time s together I SATA : HIFU intensity of spatial average and temporal average, HIFU irradiated area : means the cross-sectional area at the HIFU focal point . These energy values were evaluated statistically using a t-test and the outcome was expressed as means + /-S.D.
In addition, specimens of the trachea and surrounding tissues obtained from both experiments were stained with hematoxylin-eosin HE to histologically evaluate the physical and/or mechanical effects of HIFU exposure.
These experiments were approved by the Animal Research Committee of the National Center for Child Health and Development Approval No. A2006-007-C07 according to the Institutional Animal Care and Use Committee guidelines.
Results

Experiment 1
In all ve rabbits, the balloon was destroyed by bursting almost instantaneously Table 1 . In four rabbits in which the balloon was placed between the vocal cord and the manubrium, balloon destruction was con rmed in the course of the rst cycle of HIFU irradiation, whereas balloon destruction was recognized in the third cycle of HIFU exposure in a single case in which the balloon was accidentally placed just under the manubrium and carina.
The histological examination of the tracheal tissue demonstrated no clear thermal injury or denaturation at the site of HIFU irradiation. Although mechanical injury of the tracheal membranous wall was identi ed in four of the ve animals Fig. 2A , there was no evidence of likely thermal denaturation or coagulation as a direct effect of HIFU exposure Fig. 2B . Indeed, the mechanical injury was observed fetoscopically in the course of initial balloon in ation in the trachea. Meanwhile, in two of the ve animals, histological HIFU injuries were observed on the skin surface overlying the HIFU-exposed balloon Fig. 3A , B .
Experiment 2
In one of the six cases, the balloons burst like those destroyed in experiment 1, while the remaining five balloons showed progressive deflation with an ultimate shrinkage within 12-24 hours at room temperature Table 2 . The de ation of ve balloons was probably due to a gradual slow leak of the injected uid through the balloon wall through a minute ssure that was detected subsequently following a forceful injection of saline. Two of the six cases showed mechanical injury of the tracheal membranous wall as observed in experiment 1. Two of the six animals also showed injury to the skin lying over the HIFU- Tables 1 and 2 also detail the total dose of HIFU energy output in experiments 1 and 2, respectively. As shown in Fig. 4 , no signi cant difference in the delivered HIFU energy was found on average between the two experiments.
Discussion
In this study, we demonstrated that the trachea with a balloon occlusion can be re-opened instantaneously by HIFU irradiation alone. This experimental outcome suggests a strong likelihood that a fetus undergoing FETO to treat severe lung hypoplasia would not have to withstand a second prenatal fetoscopy to remove the balloon. HIFU has already been clinically used to ablate diverse tumors including prostate and breast cancers 11 12 as well as an acardiac twin to save the pump twin in cases of twin reversed arterial perfusion sequence 13 .
Using an ultra-slow video camera and a transparent silicone tube as a substitute for an animal trachea, we could model a detailed process of HIFU destruction of the balloon 14 . Interestingly, destruction or de ation of the intratracheal balloon using HIFU by our procedure did not seem to depend on its thermal effect alone, unlike in cases of tumor or tissue ablation. In our animal models, the HIFU irradiation rst caused the uid injected into the balloon to evaporate and form collections of minute gaseous bubbles, which rapidly expanded to a dense cluster located immediately beneath the front of the balloon. These bubbles are presumed to ultrasonically injure the front of the balloon owing to their large acoustic impedance, which provides the HIFU with high re ectivity unpublished data . Worthy of note, we found no evidence of increased pressure on the silicone tube from inside the balloon immediately before bursting. and Experiment 2 N 6 . There was no significant difference between the results from experimental groups 1 and 2, unpaired t-test t 9 1.01, P 0.34 .
In our experiment, the uid for balloon injection was a mixture of per uorocarbon Nanodroplet and clinically available ultrasound contrast medium Sonazoid , both of which are proven to be clinically safe for human subjects. Per uorocarbon is quite evaporative and biologically inactive, and can dissolve a large quantity of oxygen, leading to its clinical adoption for liquid ventilation in which fully oxygenated per uorocarbon is injected into the trachea of human patients with severe respiratory dysfunction. In our case, we tested a substance produced from per uorocarbon i.e., Nanodroplet to achieve HIFU destruction of the balloon because it was stable but readily gasi ed using HIFU, generating innumerable minute bubbles at a low temperature.
Along with our successful release of experimental tracheal occlusion, we encountered two categories of collateral damage in the entire course of the HIFU procedure. This damage comprised skin and subcutaneous tissue injuries and lacerations of the membranous back wall of the trachea.
First, the injuries to the skin and its underlying tissue in the direct path of the HIFU beam were assumed to be from mechanical and thermal causes. Mechanical injuries have been associated previously with the generation of standing waves overlying the border between the outside degassed water and the epidermal tissue. These waves, which are formed by re ected acoustic waves and endowed with doubly high acoustic pressure, are likely to cause intradermal cavitation with associated production of destructive shock waves 15 . In addition, it has been suggested that vibratory energy converted from HIFU energy within the dermal tissue enables heat production, which subsequently provokes thermal injury. The mechanism underlying other skin injuries probably involves diverse multiple causes including a pre-planned sequence of HIFU exposure and the intratracheal location of the balloon, which potentially affects the angle of HIFU beam incidence and HIFU energy availability. Indeed, we found a tendency for reduced skin injuries when HIFU irradiation was carried out with a short-time interruption between HIFU exposure cycles experiment 2 . Meanwhile, we could not nd any distinct correlations between the skin injuries and total dose of delivered HIFU energy. Another major issue was a gross injury of the tracheal membranous back wall. This apparently mechanical injury was not caused by a rapid rise in the balloon pressure associated with its burst, but instead by balloon over-distension with an excessive injection volume experiment 1 . Experiment 2 subsequently revealed that we could achieve substantial reduction in the incidence of such injury by in ating the balloon with a smaller amount of uid.
It should be noted that the outcome of our microscopic studies in the two described experiments was quite limited in terms of biological significance because we obtained the tissue specimens from experimental animals that were dead before the start of the procedure. Accordingly, we should use live animals in future to accurately investigate the histopathological damage caused by the HIFU procedure.
In conclusion, our feasibility study demonstrated that the FETO procedure could possibly be completed using HIFU alone, thus totally avoiding the currently required second fetoscopy. It is also expected that this development will enhance the safety and clinical uptake of the FETO procedure, leading to improved therapeutic outcomes for fetal lung hypoplasia associated with CDH. We plan to further develop this promising HIFU technique.
